These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 14984919)

  • 1. Impaired fasting glucose and cardiogenic shock in patients with acute myocardial infarction.
    Zeller M; Cottin Y; Brindisi MC; Dentan G; Laurent Y; Janin-Manificat L; L'Huillier I; Beer JC; Touzery C; Makki H; Verges B; Wolf JE;
    Eur Heart J; 2004 Feb; 25(4):308-12. PubMed ID: 14984919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High plasma N-terminal pro-brain natriuretic peptide level found in diabetic patients after myocardial infarction is associated with an increased risk of in-hospital mortality and cardiogenic shock.
    Vergès B; Zeller M; Desgrès J; Dentan G; Laurent Y; Janin-Manificat L; L'Huillier I; Rioufol G; Beer JC; Makki H; Rochette L; Gambert P; Cottin Y
    Eur Heart J; 2005 Sep; 26(17):1734-41. PubMed ID: 15831555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of fasting glucose levels on mortality rate in patients with and without diabetes mellitus and coronary artery disease undergoing percutaneous coronary intervention.
    Muhlestein JB; Anderson JL; Horne BD; Lavasani F; Allen Maycock CA; Bair TL; Pearson RR; Carlquist JF;
    Am Heart J; 2003 Aug; 146(2):351-8. PubMed ID: 12891207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between blood glucose on admission and prognosis in patients with acute myocardial infarction treated with percutaneous coronary intervention.
    Gasior M; Stasik-Pres G; Pres D; Lech P; Gierlotka M; Lekston A; Hawranek M; Tajstra M; Kalarus Z; Poloński L
    Kardiol Pol; 2007 Sep; 65(9):1031-8; discussion 1039-40. PubMed ID: 17975750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of myocardial reperfusion in patients with fasting blood glucose < or =100, 101 to 125, and >125 mg/dl and ST-elevation myocardial infarction with percutaneous coronary intervention.
    Fefer P; Hod H; Ilany J; Shechter M; Segev A; Novikov I; Guetta V; Matetzky S
    Am J Cardiol; 2008 Dec; 102(11):1457-62. PubMed ID: 19026295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High fasting glucose levels as a predictor of worse clinical outcome in patients with coronary artery disease: results from the Bezafibrate Infarction Prevention (BIP) study.
    Arcavi L; Behar S; Caspi A; Reshef N; Boyko V; Knobler H
    Am Heart J; 2004 Feb; 147(2):239-45. PubMed ID: 14760320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does glucose level at hospital discharge predict one-year mortality in patients with diabetes mellitus treated with percutaneous coronary intervention for ST-segment elevation myocardial infarction?
    Gasior M; Pres D; Stasik-Pres G; Lech P; Gierlotka M; Lekston A; Hawranek M; Tajstra M; Kalarus Z; Poloński L
    Kardiol Pol; 2008 Jan; 66(1):1-8; discussion 9-11. PubMed ID: 18266182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In patients with ST-segment elevation myocardial infarction with cardiogenic shock treated with percutaneous coronary intervention, admission glucose level is a strong independent predictor for 1-year mortality in patients without a prior diagnosis of diabetes.
    Vis MM; Sjauw KD; van der Schaaf RJ; Baan J; Koch KT; DeVries JH; Tijssen JG; de Winter RJ; Piek JJ; Henriques JP
    Am Heart J; 2007 Dec; 154(6):1184-90. PubMed ID: 18035093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of fasting glycemia on short-term prognosis after acute myocardial infarction.
    Vergès B; Zeller M; Dentan G; Beer JC; Laurent Y; Janin-Manificat L; Makki H; Wolf JE; Cottin Y
    J Clin Endocrinol Metab; 2007 Jun; 92(6):2136-40. PubMed ID: 17426093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired fasting glucose is associated with increased arterial stiffness in elderly people without diabetes mellitus: the Rotterdam Study.
    van Popele NM; Elizabeth Hak A; Mattace-Raso FU; Bots ML; van der Kuip DA; Reneman RS; Hoeks AP; Hofman A; Grobbee DE; Witteman JC
    J Am Geriatr Soc; 2006 Mar; 54(3):397-404. PubMed ID: 16551305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Admission glucose concentrations independently predict early and late mortality in patients with acute myocardial infarction treated by primary or rescue percutaneous coronary intervention.
    Straumann E; Kurz DJ; Muntwyler J; Stettler I; Furrer M; Naegeli B; Frielingsdorf J; Schuiki E; Mury R; Bertel O; Spinas GA
    Am Heart J; 2005 Nov; 150(5):1000-6. PubMed ID: 16290985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma concentrations of interleukin-6, organ failure, vasopressor support, and successful coronary revascularization in predicting 30-day mortality of patients with cardiogenic shock complicating acute myocardial infarction.
    Geppert A; Dorninger A; Delle-Karth G; Zorn G; Heinz G; Huber K
    Crit Care Med; 2006 Aug; 34(8):2035-42. PubMed ID: 16775569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fasting glucose is an important independent risk factor for 30-day mortality in patients with acute myocardial infarction: a prospective study.
    Suleiman M; Hammerman H; Boulos M; Kapeliovich MR; Suleiman A; Agmon Y; Markiewicz W; Aronson D
    Circulation; 2005 Feb; 111(6):754-60. PubMed ID: 15699267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical features and treatment of cardiogenic shock complicated with acute myocardial infarction].
    Zhao YS; Wang SW; Lu CY; Wu XL; Li YF; Liu LL; Yan MY; Cheng R
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2004 Mar; 16(3):148-50. PubMed ID: 15009960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mortality after emergent percutaneous coronary intervention in cardiogenic shock secondary to acute myocardial infarction and usefulness of a mortality prediction model.
    Klein LW; Shaw RE; Krone RJ; Brindis RG; Anderson HV; Block PC; McKay CR; Hewitt K; Weintraub WS;
    Am J Cardiol; 2005 Jul; 96(1):35-41. PubMed ID: 15979429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electrocardiographic findings in cardiogenic shock, risk prediction, and the effects of emergency revascularization: results from the SHOCK trial.
    White HD; Palmeri ST; Sleeper LA; French JK; Wong CK; Lowe AM; Crapo JW; Koller PT; Baran KW; Boland JL; Hochman JS; Wagner GS;
    Am Heart J; 2004 Nov; 148(5):810-7. PubMed ID: 15523311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic characteristics and insulin resistance of impaired fasting glucose among the middle-aged and elderly Taiwanese.
    Chen LK; Lin MH; Chen ZJ; Hwang SJ; Tsai ST; Chiou ST
    Diabetes Res Clin Pract; 2006 Feb; 71(2):170-6. PubMed ID: 16026886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High risk of cardiovascular mortality in individuals with impaired fasting glucose is explained by conversion to diabetes: the Hoorn study.
    Rijkelijkhuizen JM; Nijpels G; Heine RJ; Bouter LM; Stehouwer CD; Dekker JM
    Diabetes Care; 2007 Feb; 30(2):332-6. PubMed ID: 17259503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are even impaired fasting blood glucose levels preoperatively associated with increased mortality after CABG surgery?
    Anderson RE; Klerdal K; Ivert T; Hammar N; Barr G; Owall A
    Eur Heart J; 2005 Aug; 26(15):1513-8. PubMed ID: 15800018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of in-hospital mortality after percutaneous coronary intervention for cardiogenic shock.
    Valente S; Lazzeri C; Vecchio S; Giglioli C; Margheri M; Bernardo P; Comeglio M; Chiocchini S; Gensini GF
    Int J Cardiol; 2007 Jan; 114(2):176-82. PubMed ID: 16737749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.